GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » Forward Dividend Yield %

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Forward Dividend Yield % : 0.00% (As of May. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Forward Dividend Yield %?

As of today (2024-05-21), the Forward Annual Dividend Yield of Santhera Pharmaceuticals Holding AG is 0.00%.

As of today (2024-05-21), the Trailing Annual Dividend Yield of Santhera Pharmaceuticals Holding AG is 0.00%.

XSWX:SANN's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.555
* Ranked among companies with meaningful Forward Dividend Yield % only.

Santhera Pharmaceuticals Holding AG's Dividends per Share for the six months ended in Jun. 2023 was CHF0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Santhera Pharmaceuticals Holding AG's Forward Dividend Yield %

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santhera Pharmaceuticals Holding AG's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Forward Dividend Yield % falls into.



Santhera Pharmaceuticals Holding AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Santhera Pharmaceuticals Holding AG  (XSWX:SANN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Santhera Pharmaceuticals Holding AG Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Traded in Other Exchanges
Address
Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines